Yearly Trends and In-Hospital Outcomes of Patients Undergoing Transcatheter Mitral Valve-In-Valve Replacement in Prosthetic Valve Dysfunction

Transcatheter mitral valve-in-valve replacement (TMVR ViV) is becoming a favorable, less invasive procedure among high-risk patients to manage mitral valve dysfunction. We aimed to investigate the trends of the predictors and outcomes of the procedure. The national inpatient sample databases of 2016...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2024-12
Main Authors: Jamshed, Aneeza, Gajjar, Rohan, Vardar, Ufuk, Abbasi, Ayesha, Karki, Sadichhya, Kumi, Dennis, Kumar, Manoj, Aziz, Imran, Bello, Jeremiah, Dhar, Gaurav, Jolly, Neeraj, Vij, Aviral
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Transcatheter mitral valve-in-valve replacement (TMVR ViV) is becoming a favorable, less invasive procedure among high-risk patients to manage mitral valve dysfunction. We aimed to investigate the trends of the predictors and outcomes of the procedure. The national inpatient sample databases of 2016-2020 were analyzed using STATA 17 software and ICD-10 codes for TMVR ViV, with stratification for mitral stenosis (MS) or Mitral regurgitation (MR) as etiology for prosthetic valve dysfunction. The primary outcome was inpatient mortality, whereas myocardial infarction and stroke were secondary outcomes. Over the 5 years, a total of 5233 patients with TMVR ViV were found, exhibiting a yearly increase of procedural volume from 490 in 2016 to 1400 patients in 2020 and decreasing odds for inpatient mortality (aOR 0.74, p = 0.53 in 2017 to aOR: 0.33, p 
ISSN:1522-726X